Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400092466Phase 4Not yet recruiting
Phase 4 trial of remimazolam and midazolam in anxiety disorder (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Wake up time. Planned start Nov 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400092466.